Join leading experts and innovators in the field of microbiome therapeutic development this September in Boston, MA, for the latest updates and strategic insights to help you take the most efficient route to market.
Hear from senior level experts from the likes of Enterome, Axial Biotherapeutics, Janssen RandD, Seres Therapeutics, Center for Microbiome Research and many more, as we explore how to overcome the challenges with RandD programs, clinical development, sequencing methods, sample and data collection, manufacturing, commercialization and regulatory compliance.
Plus, brand new for 2019, join your peers for a full day packed with microbiome focused panel discussions and access to our dedicated partnering tool, partneringONE®, giving you the opportunity to browse the attendee list, connect with fellow participants, arrange one-to-one meetings with some of the industry's top names, and grow your microbiome industry network.
For sponsorship and exhibition opportunities, please contact: Perri.Lucatello@KNect365.com
Industry: Pharma, Biotech, Microbiome Therapeutics and Supplier, Vendor, Consultant, Technology Provider Companies: USD 1899.0
Academic: USD 899.0
Speakers: Rodolphe Clerval, CBO at Enterome, David Donabedian, PhD, CEO, Co-Founder at Axial Biotherapeutics, Salvatore Morello, Senior Director, Global Regulatory Affairs at Janssen R and D, Beth McCormick, Founder at Center for Microbiome Research, David Liu, PhD, Professor at Broad Institute and Harvard University, Luk Vandenberghe, PhD, Director, Grousbeck Gene Therapy Center at Massachusetts Eye and Ear, Regina Au, Principal at BioMarketing Insight, Raul Cano, CSO at The BioCollective, Nancy C Caralla, Founding President, Executive Director at Clostridium Difficile Infections, Bharat Dixit, VP of Bioprocess and Analytical Development at Finch Therapeutics, Bonnie Feldman, Healthcare Corporate Development Consulting at DrBonnie360, USA, Elliott Friedman, Senior Research Investigator at PennCHOP Microbiome Program, Laurie Glimcher, MD, President and CEO at Dana-Farber Cancer Institute, Lee Jones, Founder, President and CEO at Rebiotix, USA, Orli Kadoch, VP of Business Development at USA, Todd Krueger, Chief Executive Officer and President at AOBiome, Chengwei Luo, CEO at DeepBiome Therapeutics, Ankit Mahadevia, CEO at Spero Therapeutics, Cindy Perettie, CEO at Foundation Medicine, Saurabh Saha, MD, PhD, Senior Vice President RandD and Global Head of Translational Medicine at Bristol-Myers Squibb, Mark Smith, CEO at Finch Therapeutics, Erik Spek, Vice President - Head of Legal Affairs and IP at Vedanta Biosciences, Inc., USA, Lilly Stairs, Head of Patient Advocacy at Clara Health, Phil Strandwitz, Co-founder and CEO at Holobiome, USA, Sonia Timberlake, VP Research, acting Head of Data Science at Finch Therapeutics, USA, James Weston, MBA, Senior Vice President of Regulatory Affairs at Seres Therapeutics